Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Amgen and Genzyme are pursuing disruptive ways of making biological drugs.
Whole genomes can now be sequenced and analyzed in about two days, which could greatly benefit newborns in a medical crisis.
Tracing bacterial genomes revealed the surprising way that an infection spread throughout a hospital.
The rise and fall of certain proteins can indicate dementia’s onset decades before the appearance of symptoms.
The technique was once considered too error-prone to be useful, but a computational fix could bring it into the world of medical research.
A similar design could lead to chips that detect drug-resistant strains of HIV and tuberculosis.
An unprecedented study shows how personalized medicine could help head off disease.
The results show that the treatment can be safe, but whether it can be effective is another question.
A newly identified hormone acts like a workout, and transforms bad fat into good.
Researchers create a genetic oddity in pursuit of a more versatile cell.